Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human, Mouse, Rat|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Synthetic peptides corresponding to residues 66-81 and 135-151 of human INHAT-1.|
|Storage buffer||PBS with 100µg/ml BSA|
|Contains||0.02% sodium azide|
|Storage Conditions||Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.|
|Tested Applications||Dilution *|
|Western Blot (WB)||1-2 µg/ml|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
The immunogen sequence is 100% identical in mouse and rat.
Suggested positive control: Jurkat whole cell lysate.
INHAT (inhibitor of acetyltransferases) complex binds to histones and masks them from being substrate for acetyltransferase. Endogenous INHAT subunits, which include the Set/TAF-Ibeta oncoprotein, associate with chromatin in vivo and can block coactivator mediated transcription when transfected in cells.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
HLA-DR-associated protein II; I-2PP2A; inhibitor of granzyme A-activated DNase; inhibitor-2 of protein phosphatase-2A; liver regeneration-related protein LRRGR00002; phosphatase 2A inhibitor I2PP2A; protein phosphatase type 2A inhibitor; protein SET; SET nuclear oncogene; SET translocation; SET translocation (myeloid leukemia-associated); TAF-1a; TAF-1b; TAF-I; template-activating factor I; Template-Activating Factor-I, chromatin remodelling factor
2610030F17Rik; 2PP2A; 5730420M11Rik; AA407739; Ab1-115; I-2PP2A; I2PP2A; IGAAD; IPP2A2; PHAPII; SET; StF-IT-1; TAF-I; TAF-IBETA